Coherus Oncology (CHRS) Non-Current Deffered Revenue (2013 - 2017)
Coherus Oncology's Non-Current Deffered Revenue was $725,000 in Q1 2017, down 97.8% from $32.97 million a year earlier but up 8.4% from the prior quarter.
Powered by 
Analysis
Coherus Oncology (CHRS) Non-Current Deffered Revenue (2013 - 2017) Analysis & Trends
At the end of FY2016, Non-Current Deffered Revenue at Coherus Oncology came in at $669,000, down 98.5% from FY2015.
- Non-Current Deffered Revenue shows a three-year compound annual growth rate of -71.4% (FY2013 to FY2016).
- In earlier years, Non-Current Deffered Revenue was $45.34 million in FY2015 (+13.6%), $39.9 million in FY2014 (+39.7%) and $28.57 million in FY2013.
- Quarterly Non-Current Deffered Revenue has moved between $595,000 (Q3 2016) and $45.34 million (Q4 2015) over five years.
- Compared with a year earlier, Non-Current Deffered Revenue has declined for five straight quarters, with an average decline of 48.4% over the last seven quarters.
- The best year-over-year quarter for Non-Current Deffered Revenue over five years was Q4 2014 (growth of 39.7%); the worst was Q4 2016 (a decline of 98.5%).
- Per Business Quant data, CHRS's Non-Current Deffered Revenue in the three quarters before Q1 2017 was $669,000 (Q4 2016), $595,000 (Q3 2016) and $26.79 million (Q2 2016).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,122.91 Bn | 1,091.50 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 615.09 Bn | 533.62 Bn | 17.26 Bn | - |
| 3 | AbbVie | 504.75 Bn | 477.86 Bn | 12.70 Bn | - |
| 4 | Merck | 360.18 Bn | 314.55 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 292.05 Bn | 256.04 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 256.09 Bn | 229.78 Bn | 12.86 Bn | - |
| 7 | Amgen | 233.63 Bn | 189.02 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 194.49 Bn | 168.69 Bn | 6.22 Bn | - |
| 9 | Pfizer | 168.35 Bn | 114.99 Bn | 10.94 Bn | - |
| 10 | Coherus Oncology | 155.59 Mn | -480.55 Mn | 10.07 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2017 | 725,000.00 |
| Dec 31, 2016 | 669,000.00 |
| Sep 30, 2016 | 595,000.00 |
| Jun 30, 2016 | 26.79 Mn |
| Mar 31, 2016 | 32.97 Mn |
| Dec 31, 2015 | 45.34 Mn |
| Sep 30, 2015 | 33.45 Mn |
| Jun 30, 2015 | 38.49 Mn |
| Mar 31, 2015 | 34.40 Mn |
| Dec 31, 2014 | 39.90 Mn |
| Sep 30, 2014 | 43.53 Mn |
| Dec 31, 2013 | 28.57 Mn |
API Access
Coherus Oncology Non-Current Deffered Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=CHRS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-deffered-revenue", "ticker": "CHRS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=CHRS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();